A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral activity and safety of tenofovir
disoproxil fumarate (TDF) in Asian-American adults (self-reported Asian descent, living in
the United States) with chronic hepatitis B infection. All participants will receive active
treatment with TDF for 48 weeks.